Avantor, Inc. (NYSE:AVTR - Get Free Report) Director Simon Dingemans bought 25,000 shares of the business's stock in a transaction on Friday, May 1st. The stock was bought at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the purchase, the director directly owned 25,000 shares of the company's stock, valued at $203,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Avantor Price Performance
AVTR opened at $8.05 on Wednesday. The business's 50-day moving average is $8.12 and its two-hundred day moving average is $10.41. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The firm has a market capitalization of $5.49 billion, a PE ratio of -9.93, a price-to-earnings-growth ratio of 4.66 and a beta of 0.94.
Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The firm's quarterly revenue was up .0% compared to the same quarter last year. Research analysts anticipate that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
AVTR has been the topic of a number of research analyst reports. Morgan Stanley set a $10.00 price target on Avantor in a research note on Friday, February 13th. Zacks Research upgraded Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 30th. Evercore set a $10.00 price target on Avantor in a research note on Wednesday, February 11th. Citigroup dropped their price target on Avantor from $11.00 to $9.00 and set a "neutral" rating on the stock in a research note on Thursday, April 30th. Finally, UBS Group restated a "neutral" rating and set a $10.50 price target on shares of Avantor in a research note on Thursday, February 12th. Three research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $11.39.
View Our Latest Analysis on AVTR
Institutional Investors Weigh In On Avantor
A number of large investors have recently modified their holdings of the business. TD Private Client Wealth LLC grew its stake in shares of Avantor by 9.2% during the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company's stock worth $100,000 after acquiring an additional 670 shares during the last quarter. Private Trust Co. NA boosted its position in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock valued at $32,000 after buying an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company's stock valued at $49,000 after buying an additional 905 shares during the last quarter. TD Waterhouse Canada Inc. boosted its position in Avantor by 2.5% in the third quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company's stock valued at $532,000 after buying an additional 966 shares during the last quarter. Finally, Evergreen Capital Management LLC boosted its position in Avantor by 7.7% in the third quarter. Evergreen Capital Management LLC now owns 14,347 shares of the company's stock valued at $179,000 after buying an additional 1,026 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.
Avantor Company Profile
(
Get Free Report)
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
